Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ohman

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
The American Journal of Cardiology|April 1, 1993
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)G D Chapman, E M Ohman, E J Topol, et al.
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
The American Journal of Cardiology|November 15, 1995
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupA Barbagelata, C B Granger, E J Topol, et al.
The American Journal of Cardiology|November 15, 2000
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupR H Christenson, R T Vollmer, E M Ohman, et al.
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
Clinical Chemistry|June 1, 1995
Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study GroupR H Christenson, E M Ohman, E J Topol, et al.
American Heart Journal|October 1, 1993
Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial InfarctionE M Ohman, R H Christenson, R M Califf, et al.
American Heart Journal|March 1, 1991
The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupE M Ohman, R M Califf, B S George, et al.
Circulation|August 1, 1994
Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study GroupE M Ohman, B S George, C J White, et al.
Circulation|September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trialsM P Hudson, C B Granger, E J Topol, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
The American Journal of Cardiology|April 1, 1993
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)G D Chapman, E M Ohman, E J Topol, et al.
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
The American Journal of Cardiology|November 15, 1995
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupA Barbagelata, C B Granger, E J Topol, et al.
The American Journal of Cardiology|November 15, 2000
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupR H Christenson, R T Vollmer, E M Ohman, et al.
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
Clinical Chemistry|June 1, 1995
Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study GroupR H Christenson, E M Ohman, E J Topol, et al.
American Heart Journal|October 1, 1993
Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial InfarctionE M Ohman, R H Christenson, R M Califf, et al.
American Heart Journal|March 1, 1991
The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupE M Ohman, R M Califf, B S George, et al.
Circulation|August 1, 1994
Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study GroupE M Ohman, B S George, C J White, et al.
Circulation|September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trialsM P Hudson, C B Granger, E J Topol, et al.
Pageof 19